Novel cancer treatment wins endorsement of FDA advisers

Although the agency is not bound by the panel's recommendation, it is likely to follow suit. Its decision is expected by late September.

Read the full post at Health and Science
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive